Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Hemispherx Biopharma, Inc. is a biopharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx’s flagship products include Alferon N Injection® and the experimental therapeutics Ampligen® and Oragens®. Alferon N Injection® is approved for a category of STD infection, and Ampligen® and Oragens® represent experimental RNA nucleic acids being developed for globally important viral diseases and disorders of the immune system. Hemispherx’s platform technology includes large and small agent components for potential treatment of various severely debilitating and life threatening ( www.hemispherx.net )
Hemispherx Biopharma , Inc.
1617 JFK Boulevard Suite 660
Philadelphia, PENNSYLVANIA 19103
USA
Tel: (215) 988-0080
Fax: (215) 988-1739